Highlights and Quick Summary
- Capex/Depreciation for the quarter ending June 30, 2022 was -2.17 (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation decreased by -Infinity%
- Annual Capex/Depreciation for 2022 was -0.08 (a -91.87% decrease from previous year)
- Annual Capex/Depreciation for 2021 was -0.96 (a -Infinity% decrease from previous year)
- Annual Capex/Depreciation for 2021 was 0.0 (a -100.0% decrease from previous year)
- Twelve month Capex/Depreciation ending June 30, 2022 was -0.18 (a -Infinity% decrease compared to previous quarter)
- Twelve month trailing Capex/Depreciation decreased by -Infinity% year-over-year
Trailing Capex/Depreciation for the last four month:
|30 Jun '22||31 Mar '22||31 Dec '21||30 Sep '21|
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Benitec Biopharma LimitedMost recent Capex/Depreciationof BNTC including historical data for past 10 years.
Interactive Chart of Capex/Depreciation of Benitec Biopharma Limited
Benitec Biopharma Limited Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
Business Profile of Benitec Biopharma Limited